Welcome back Nathan.
On your claim: please show where the new scanners allow same/better sensitivity than old scanners using 64Cu-SAR-bisPSMA?
I can help: there is no such evidence. Rather:
a) Scanners are tracer agnostic: they can use Ga68, F18, and Cu64.
b) Cu6 makes tracers and not scanners, and, just as 64Cu-SAR-bisPSMA performs betteer than Ga68 and F18 in old scanners, science says that it will perform better in the new LAFOV scanners. Its the tracer that lights up, not the machine.
I agree that Telix is a brilliant company. Taking a generic that anyone else is free to use, and creating a billion dollars a year grossing product, shows exceptional talent and business acumen.
Taking time to create a Best in Class product, when others are doing some hotchpotch stuff that they are rushing, poorly tested, to market, takes a huge amount of integrity and ethics. In the end, Science will win.
- Forums
- ASX - By Stock
- CU6
- Ann: Clarity to present COBRA and CLARIFY abstracts
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
5.44%
!
$2.52

Ann: Clarity to present COBRA and CLARIFY abstracts, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.52 |
Change
0.130(5.44%) |
Mkt cap ! $810.1M |
Open | High | Low | Value | Volume |
$2.39 | $2.54 | $2.37 | $5.141M | 2.072M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6820 | $2.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.52 | 3500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 405 | 2.500 |
1 | 20000 | 2.480 |
4 | 41204 | 2.450 |
1 | 5000 | 2.410 |
5 | 3695 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.520 | 3500 | 1 |
2.540 | 37102 | 3 |
2.550 | 30520 | 6 |
2.580 | 30000 | 2 |
2.590 | 10004 | 2 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online